Jeffrey Trigilio

Director of Finance/CFO at XOMA ROYALTY CORPORATION

42 year

Health Technology

Consumer Services

Finance

Profile

Jeffrey Trigilio is currently Chief Financial Officer at XOMA Royalty Corp.
Former positions include Chief Executive Officer, CFO & Secretary at Cullinan Mica Corp., Director-Healthcare Investment Banking at RBC Capital Markets LLC from 2017 to 2018, Chief Operating & Financial Officer at Obsidian Therapeutics, Inc., Head-Sales at Bayer AG, Chief Financial Officer at Amylyx Pharmaceuticals, Inc. in 2020, Chief Financial Officer at Cullinan Oncology LLC, Vice President-Corporate Finance at Bluerock Therapeutics, Inc. from 2018 to 2020, and Chief Financial Officer & Treasurer at Cullinan Therapeutics, Inc. from 2020 to 2024.
Education includes an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University.

Jeffrey Trigilio active positions

Companies	Position	Start
XOMA ROYALTY CORPORATION	Director of Finance/CFO	2026-01-11

All active positions of Jeffrey Trigilio

Former positions of Jeffrey Trigilio

Companies	Position	End
CULLINAN THERAPEUTICS, INC.	Director of Finance/CFO	2024-03-28
AMYLYX PHARMACEUTICALS, INC.	Director of Finance/CFO	2020-06-30
Bluerock Therapeutics, Inc. Bluerock Therapeutics, Inc. BlueRock Therapeutics is a clinical stage cell therapy company that aims to transform the treatment of degenerative diseases through cell therapy. The company, a wholly-owned subsidiary of Bayer AG, operates as a cornerstone of its Cell & Gene Therapy Platform. BlueRock's mission is to discover and develop cell therapies that can change the way diseases are treated and improve the lives of patients. The team is committed to realizing the potential of regenerative medicine to help patients suffering from disease by developing new and impactful cellular therapies. BlueRock is based in New York.	Corporate Officer/Principal	2019-12-31
RBC Capital Markets LLC RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	2018-07-31
Obsidian Therapeutics, Inc. Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors	Director of Finance/CFO	-

See the detail of Jeffrey Trigilio's experience

Training of Jeffrey Trigilio

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Trigilio's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Bayer AG Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services	Health Technology
XOMA Royalty Corp. XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
RBC Capital Markets LLC RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases	Health Technology
Cullinan Mica Corp. Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Develops immuno-oncology therapeutics	Health Technology
Obsidian Therapeutics, Inc. Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors	Health Technology
Cullinan Oncology LLC Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments	Finance
Cullinan Oncology, Inc. Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Bluerock Therapeutics, Inc. Bluerock Therapeutics, Inc. BlueRock Therapeutics is a clinical stage cell therapy company that aims to transform the treatment of degenerative diseases through cell therapy. The company, a wholly-owned subsidiary of Bayer AG, operates as a cornerstone of its Cell & Gene Therapy Platform. BlueRock's mission is to discover and develop cell therapies that can change the way diseases are treated and improve the lives of patients. The team is committed to realizing the potential of regenerative medicine to help patients suffering from disease by developing new and impactful cellular therapies. BlueRock is based in New York.